Parent stem cells offer new hope for kids with blood cancer
NCT ID NCT03431090
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to do stem cell transplants for 20 children with blood cancers or myelodysplasia who don't have a perfect donor match. Doctors remove certain immune cells from a parent's partially matched stem cells before transplant to help the new cells grow faster and lower the risk of graft-versus-host disease (GVHD), a serious side effect. The goal is to improve recovery and survival while reducing complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could End-of-Life care for blood cancer patients be done at home?
- Could bone marrow from deceased donors cure blood cancers?
- Plant pigment could soothe Radiation's harsh side effect in blood cancer treatment
- New 'WARNING Pack' aims to protect quality of life in older cancer patients
- Wearable patch and phone app could spot dangerous fevers before they spike in cancer therapy
- Cord blood cells aim to speed platelet recovery in transplant patients